Among female BRCA1 and BRCA2 carriers, a recent study found that oral contraceptive use is associated with an increased risk of breast cancer, but only among users who have been using them for more than five years, while ovarian cancer risk was nearly cut in half.
Use the link in bio to learn more!
Reference: Park, et al. Carcinogenesis. 2022;43(3):231-242. PMID: 34958358.